کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
2080726 | 1545173 | 2009 | 9 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Organometallic compounds in oncology: implications of novel organotins as antitumor agents
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
موضوعات مرتبط
علوم زیستی و بیوفناوری
بیوشیمی، ژنتیک و زیست شناسی مولکولی
بیوتکنولوژی یا زیستفناوری
پیش نمایش صفحه اول مقاله
چکیده انگلیسی
Since the introduction of cisplatin in cancer therapy, metal complexes and organometallic compounds have been gaining growing importance in oncology.The impressive clinical effectiveness of cisplatin is limited by significant side effects and the emergence of drug resistance. Thus, novel classic and unconventional PtII and PtIV complexes have been introduced in therapy or are presently in advanced clinical trials.Moreover, innovative non-platinum metal-based antitumor agents, whose activity does not rely on direct DNA damage and may involve proteins and enzymes, have been developed.Gold and tin derivatives are enjoying an increasing interest and appear very promising as potential drug candidates.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Drug Discovery Today - Volume 14, Issues 9–10, May 2009, Pages 500–508
Journal: Drug Discovery Today - Volume 14, Issues 9–10, May 2009, Pages 500–508
نویسندگان
Angela Alama, Bruno Tasso, Federica Novelli, Fabio Sparatore,